ENTITY
Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine (600276 CH)

263
Analysis
Health CareChina
Jiangsu Hengrui Medicine Co., Ltd. develops, manufactures, and markets a variety of medicines and medicine packing materials. The Company's products include anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
more
Refresh
17 Sep 2020 01:38

JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure

$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...

Logo
443 Views
Share
17 Aug 2020 09:48

SH/​​SZ Connect Flow Weekly: East Money, BOE, Hengrui, Goertek

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to highlight key stocks and sectors which the mainland investors traded via the...

Logo
206 Views
Share
29 Jul 2020 11:01

Active Fund Manager's Favoured (And Least Favoured) China Stocks

In this report, we show 2 portfolios based on the most favoured and least favoured stocks among High Active China focused equity managers. The...

Logo
570 Views
Share
12 Jul 2020 11:26

SH/​​SZ Connect Flow Weekly: $4.3bn Inflows as Shanghai Comp Hit 3,400

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to highlight key stocks and sectors which the mainland investors traded via the...

Logo
281 Views
Share
x